By Connor Hart
Shares of Cargo Therapeutics tumbled after the company said it will cut half of its workforce, or about 58 jobs, as it stops the development of one of its drugs.
The stock fell 68%, to $4.41, in after-hours trading. Shares ended the regular session down 3.4%, at $13.19, having lost 40% of their value in the past year.
The San Carlos, Calif., company said Wednesday that the job cuts will extend its cash runway, allowing it to prioritize focus on the development of other potential treatments.
The job cuts come as Cargo Therapeutics discontinued the development of its potential treatment for certain types of blood cancer, citing results from a recent trial that don't support a competitive benefit-risk profile for the intended patient population.
Cargo employed 116 people as of Dec. 31, 2023, according to its most recent annual report filed with the Securities and Exchange Commission.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
January 29, 2025 16:58 ET (21:58 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。